Brainstem pathology and non-motor symptoms in PD

Journal of the Neurological Sciences

Volumn 289, Issue 1-2, 2010, Pages 81-88

  Grinberg, Lea Tenenholz ^a,b   Rueb, Udo ^c   Alho, Ana Tereza di Lorenzo ^a   Heinsen, Helmut ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Brainstem; Correlation; Non motor; Parkinson's disease; Pathology

Indexed keywords

ARTICLE; BRAIN NUCLEUS; BRAIN STEM; CHRONOLOGY; CONSTIPATION; DAYTIME SOMNOLENCE; DEMENTIA; DEPRESSION; DORSAL RAPHE NUCLEUS; FOREBRAIN; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT FUNCTION; HALLUCINATION; HOMEOSTASIS; HUMAN; KNOWLEDGE; MOOD; NEUROPATHOLOGY; NOCICEPTION; ORTHOSTATIC HYPERTENSION; PARASOMNIA; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIORITY JOURNAL; RESEARCH; SENSORY DYSFUNCTION; SLEEP WAKING CYCLE; SMELLING DISORDER; SPINAL CORD; SYMPTOM; TOPOGRAPHY; VAGUS NERVE NUCLEUS;

BRAIN STEM; HUMANS; PARKINSON DISEASE;

EID: 74149094680     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.08.021     Document Type: Article

References (153)

1. Poewe W. Non-motor symptoms in Parkinson's disease. Eur J Neurol 15 Suppl 1 (2008) 14-20
2. Chaudhuri K.R., Healy D.G., and Schapira A.H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5 (2006) 235-245
3. Tolosa E., Compta Y., and Gaig C. The premotor phase of Parkinson's disease. Parkinsonism Relat Disord 13 Suppl (2007) S2-S7
4. Greenfield J.G., and Bosanquet F.D. The brain-stem lesions in Parkinsonism. J Neurol Neurosurg Psychiatry 16 (1953) 213-226
5. Bethlem J., and Den Hartog Jager W.A. The incidence and characteristics of Lewy bodies in idiopathic paralysis agitans (Parkinson's disease). J Neurol Neurosurg Psychiatry 23 (1960) 74-80
6. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24 (2003) 197-211
7. Heinsen H., Arzberger T., and Schmitz C. Celloidin mounting (embedding without infiltration) - a new, simple and reliable method for producing serial sections of high thickness through complete human brains and its application to stereological and immunohistochemical investigations. J Chem Neuroanat 20 (2000) 49-59
8. Heinsen H., Arzberger T., Roggendorf W., and Mitrovic T. 3D reconstruction of celloidin-mounted serial sections. In Acta Neuropathol 374 (2004)
9. Nieuwenhuys R., Voogd J., and van Huijzen C. The human central nervous system. 4th ed (2008), New York, Springer
10. Dahlstrom A., and Fuxe K. Localization of monoamines in the lower brain stem. Experientia 5 20 (1964) 398-399
11. Mesulam M.M., Mufson E.J., Wainer B.H., and Levey A.I. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10 (1983) 1185-1201
12. Halliday G.M., Li Y.W., Blumbergs P.C., Joh T.H., Cotton R.G., Howe P.R., et al. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 27 (1990) 373-385
13. Braak H., Rub U., Gai W.P., and Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110 (2003) 517-536
14. Huang X.F., Törk I., and Paxinos G. Dorsal motor nucleus of the vagus nerve: a cytoarchitectonic and chemoarchitectonic study in the human. J Comp Neurol 330 (1993) 158-182
15. Hopkins D.A., Bieger D., deVente J., and Steinbusch W.M. Vagal efferent projections: viscerotopy, neurochemistry and effects of vagotomy. Prog Brain Res 107 (1996) 79-96
16. Saper C.B., Sorrentino D.M., German D.C., and de Lacalle S. Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease. Ann Neurol 29 (1991) 577-584
17. Benarroch E.E., Schmeichel A.M., Sandroni P., Low P.A., and Parisi J.E. Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease. Neurology 66 (2006) 378-383
18. Braak H., Ghebremedhin E., Rüb U., Bratzke H., and Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318 (2004) 121-134
19. Parkkinen L., Pirttila T., and Alafuzoff I. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 115 (2008) 399-407
20. Dickson D.W., Fujishiro H., DelleDonne A., Menke J., Ahmed Z., Klos K.J., Josephs K.A., et al. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol 115 (2008) 437-444
21. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 2nd ed (1986), Academic Press, Sydney
22. Halliday G.M., Li Y.W., Joh T.H., Cotton R.G., Howe P.R., Geffen L.B., et al. Distribution of monoamine-synthesizing neurons in the human medulla oblongata. J Comp Neurol 273 (1988) 301-317
23. Halliday G., and Tork I. Substance P-like immunoreactive fibres in the ventromedial mesencephalic tegmentum of rat. Brain Res Bull 21 (1988) 659-670
24. Rikard-Bell G.C., Tork I., Sullivan C., and Scheibner T. Distribution of substance P-like immunoreactive fibres and terminals in the medulla oblongata of the human infant. Neuroscience 34 (1990) 133-148
25. Huang X.F., and Paxinos G. Human intermediate reticular zone: a cyto- and chemoarchitectonic study. J Comp Neurol 360 (1995) 571-588
26. Törk I., MCritchie D.A., Rikard-Bell G.C., and Paxinos G. Autonomic regulatory centers in the medulla oblongata. In: Paxinos G. (Ed). The human nervous system (1990), Academic Press, San Diego 221-259
27. Sawchenko P.E., and Swanson L.W. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol 205 (1982) 260-272
28. King G.W. Topology of ascending brainstem projections to nucleus parabrachialis in the cat. J Comp Neurol 191 (1980) 615-638
29. Ross C.A., Ruggiero D.A., Joh T.H., Park D.H., and Reis D.J. Rostral ventrolateral medulla: selective projections to the thoracic autonomic cell column from the region containing C1 adrenaline neurons. J Comp Neurol 228 (1984) 168-185
30. Yamada H., Ezure K., and Manabe M. Efferent projections of inspiratory neurons of the ventral respiratory group. A dual labeling study in the rat. Brain Res 455 (1988) 283-294
31. Hurley K.M., Herbert H., Moga M.M., and Saper C.B. Efferent projections of the infralimbic cortex of the rat. J Comp Neurol 308 (1991) 249-276
32. Ter Horst G.J., Luiten P.G., and Kuipers F. Descending pathways from hypothalamus to dorsal motor vagus and ambiguus nuclei in the rat. J Auton Nerv Syst 11 (1984) 59-75
33. Saper C.B., Loewy A.D., Swanson L.W., and Cowan W.M. Direct hypothalamo-autonomic connections. Brain Res 117 (1976) 305-312
34. Bandler R., and Tork I. Midbrain periaqueductal grey region in the cat has afferent and efferent connections with solitary tract nuclei. Neurosci Lett 74 (1987) 1-6
35. Saper C.B., and Loewy A.D. Efferent connections of the parabrachial nucleus in the rat. Brain Res 197 (1980) 291-317
36. Ter Horst G.J., Copray J.C., Liem R.S., and Van Willigen J.D. Projections from the rostral parvocellular reticular formation to pontine and medullary nuclei in the rat: involvement in autonomic regulation and orofacial motor control. Neuroscience 40 (1991) 735-758
37. Nosaka S., Yamamoto T., and Yasunaga K. Localization of vagal cardioinhibitory preganglionic neurons with rat brain stem. J Comp Neurol 186 (1979) 79-92
38. Mehler W.R. Observations on the connectivity of the parvicellular reticular formation with respect to a vomiting center. Brain Behav Evol 23 (1983) 63-80
39. Hiura T. Salivatory neurons innervate the submandibular and sublingual glands in the rat: horseradish peroxidase study. Brain Res 137 (1977) 145-149
40. Loewy A.D. Descending pathways to the sympathetic preganglionic neurons. Prog Brain Res 57 (1982) 267-277
41. Braak E., Sandmann-Keil D., Rüb U., Gai W.R., de Vos R.A.I., Steur E.N.H.J., et al. Alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei. Acta Neuropathol 101 (2001) 195-201
42. Del Tredici K., Rub U., De Vos R.A., Bohl J.R., and Braak H. Where does parkinson disease pathology begin in the brain?. J Neuropathol Exp Neurol 61 (2002) 413-426
43. Azmitia E.C., and Whitaker-Azmitia P.M. Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. J Clin Psychiatry 52 Suppl (1991) 4-16
44. Whitaker-Azmitia P.M. Serotonin and brain development: role in human developmental diseases. Brain Res Bull 56 (2001) 479-485
45. Holstege G. Descending motor pathways and the spinal motor system: limbic and non-limbic components. ProgBrain Res 87 (1991) 307-412
46. Tork I. Anatomy of the serotonergic system. Ann N Y Acad Sci 600 (1990) 9-34
47. Braak H., Rüb U., Sandmann-Keil D., Gai W.P., de Vos R.A.I., Steur E.N.H.J., Arai K., and Braak E. Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol 99 (2000) 489-495
48. Olszewski J., and Baxter D. Cytoarchitecture of the human brain stem (1982), Karger, Basel
49. Winn P. How best to consider the structure and function of the pedunculopontine tegmental nucleus: evidence from animal studies. J Neurol Sci 248 (2006) 234-250
50. Mesulam M.M., Geula C., Bothwell M.A., and Hersh L.B. Human reticular formation: cholinergic neurons of pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. J Comp Neurol 281 (1989) 611-633
51. Pahapill P.A., and Lozano A.M. The pedunculopontine nucleus and Parkinson's disease. Brain 123 (2000) 1767-1783
52. Lavoie B., and Parent A. Pedunculopontine nucleus in the squirrel monkey: projections to the basal ganglia as revealed by anterograde tract-tracing methods. J Comp Neurol 344 (1994) 210-231
53. Moriizumi T., Nakamura Y., Tokuno H., Kudo M., and Kitao Y. Convergence of afferent fibers from the entopeduncular nucleus and the substantia nigra pars reticulata onto single neurons in the ventromedial thalamic nucleus: an electron microscope study in the cat. Neurosci Lett 95 (1988) 125-129
54. Semba K., and Fibiger H.C. Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: a retro- and antero-grade transport and immunohistochemical study. J Comp Neurol 323 (1992) 387-410
55. Granata A.R., and Kitai S.T. Intracellular analysis of excitatory subthalamic inputs to the pedunculopontine neurons. Brain Res 488 (1989) 57-72
56. Woolf N.J., and Butcher L.L. Cholinergic systems in the rat brain: IV. Descending projections of the pontomesencephalic tegmentum. Brain Res Bull 23 (1989) 519-540
57. Mitani A., Ito K., Hallanger A.E., Wainer B.H., Kataoka K., and McCarley R.W. Cholinergic projections from the laterodorsal and pedunculopontine tegmental nuclei to the pontine gigantocellular tegmental field in the cat. Brain Res 451 (1988) 397-402
58. Higo S., Ito K., Fuchs D., and McCarley R.W. Anatomical interconnections of the pedunculopontine tegmental nucleus and the nucleus prepositus hypoglossi in the cat. Brain Res 536 (1990) 79-85
59. Nakamura Y., Tokuno H., Moriizumi T., Kitao Y., and Kudo M. Monosynaptic nigral inputs to the pedunculopontine tegmental nucleus neurons which send their axons to the medial reticular formation in the medulla oblongata. An electron microscopic study in the cat. Neurosci Lett 103 (1989) 145-150
60. Aravamuthan B.R., Muthusamy K.A., Stein J.F., Aziz T.Z., and Johansen-Berg H. Topography of cortical and subcortical connections of the human pedunculopontine and subthalamic nuclei. Neuroimage 37 (2007) 694-705
61. Yasui Y., Cechetto D.F., and Saper C.B. Evidence for a cholinergic projection from the pedunculopontine tegmental nucleus to the rostral ventrolateral medulla in the rat. Brain Res 517 (1990) 19-24
62. Zweig R.M., Jankel W.R., Hedreen J.C., Mayeux R., and Price D.L. The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 26 (1989) 41-46
63. Ohama E., and Ikuta F. Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol 34 (1976) 311-319
64. Boeve B.F., Dickson D.W., Olson E.J., Shepard J.W., Silber M.H., Ferman T.J., et al. Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med 8 (2007) 60-64
65. Schmeichel A.M., Buchhalter L.C., Low P.A., Parisi J.E., Boeve B.W., Sandroni P., et al. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology 70 (2008) 368-373
66. Cersosimo M.G., and Benarroch E.E. Neural control of the gastrointestinal tract: implications for Parkinson disease. Mov Disord 23 (2008) 1065-1075
67. Rub U., Del Tredici K., Schultz C., Thal D.R., Braak E., and Braak H. The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei. Neuropathol Appl Neurobiol 26 (2000) 553-567
68. Baker K.G., Halliday G.M., Hornung J.P., Geffen L.B., Cotton R.G., and Tork I. Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus. Neuroscience 42 (1991) 757-775
69. Michelsen K.A., Schmitz C., and Steinbusch H.W. The dorsal raphe nucleus - from silver stainings to a role in depression. Brain Res Rev 55 (2007) 329-342
70. Porrino L.J., and Goldman-Rakic P.S. Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP. J Comp Neurol 205 (1982) 63-76
71. Hornung J.P. The human raphe nuclei and the serotonergic system. J Chem Neuroanat 26 (2003) 331-343
72. Benarroch E.E., Schmeichel A.M., Sandroni P., Parisi J.E., and Low P.A. Rostral raphe involvement in Lewy body dementia and multiple system atrophy. Acta Neuropathol 114 (2007) 213-220
73. Paulus W., and Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 50 (1991) 743-755
74. Kaufmann H., Nahm K., Purohit D., and Wolfe D. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63 (2004) 1093-1095
75. Fox E.A., and Powley T.L. Longitudinal columnar organization within the dorsal motor nucleus represents separate branches of the abdominal vagus. Brain Res 341 (1985) 269-282
76. Shapiro R.E., and Miselis R.R. The central organization of the vagus nerve innervating the stomach of the rat. J Comp Neurol 238 (1985) 473-488
77. Berthoud H.R., Carlson N.R., and Powley T.L. Topography of efferent vagal innervation of the rat gastrointestinal tract. Am J Physiol 260 (1991) R200-R207
78. Phillips R.J., Walter G.C., Wilder S.L., Baronowsky E.A., and Powley T.L. Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?. Neuroscience 153 (2008) 733-750
79. Travagli R.A., Hermann G.E., Browning K.N., and Rogers R.C. Brainstem circuits regulating gastric function. Annu Rev Physiol 68 (2006) 279-305
80. Hardoff R., Sula M., Tamir A., Soil A., Front A., Badarna S., et al. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord 16 (2001) 1041-1047
81. Pfeiffer R.F. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2 (2003) 107-116
82. Edwards L.L., Quigley E.M., Harned R.K., Hofman R., and Pfeiffer R.F. Characterization of swallowing and defecation in Parkinson's disease. Am J Gastroenterol 89 (1994) 15-25
83. Natale G., Pasquali L., Ruggieri S., Paparelli A., and Fornai F. Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation. Neurogastroenterol Motil 20 (2008) 741-749
84. Wakabayashi K., Takahashi H., Takeda S., Ohama E., and Ikuta F. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 76 (1988) 217-221
85. Quinn N.P., Koller W.C., Lang A.E., and Marsden C.D. Painful Parkinson's disease. Lancet 1 (1986) 1366-1369
86. Ford B. Pain in Parkinson's disease. Clin Neurosci 5 (1998) 63-72
87. Goetz C.G., Tanner C.M., Levy M., Wilson R.S., and Garron D.C. Pain in Parkinson's disease. Mov Disord 1 (1986) 45-49
88. Chudler E.H., and Dong W.K. The role of the basal ganglia in nociception and pain. Pain 60 (1995) 3-38
89. Brefel-Courbon C., Payoux P., Thalamas C., Ory F., Quelven I., Chollet F., et al. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 20 (2005) 1557-1563
90. Millan M.J. Descending control of pain. Prog Neurobiol 66 (2002) 355-474
91. Kuraishi Y., Fukui K., Shiomi H., Akaike A., and Takagi H. Microinjection of opioids into the nucleus reticularis gigantocellularis of the rat: analgesia and increase in the normetanephrine level in the spinal cord. Biochem Pharmacol 27 (1978) 2756-2758
92. Gebhart G.F. Descending modulation of pain. Neurosci Biobehav Rev 27 (2004) 729-737
93. Wei H., and Pertovaara A. 5-HT(1A) receptors in endogenous regulation of neuropathic hypersensitivity in the rat. Eur J Pharmacol 535 (2006) 157-165
94. Benarroch E.E. Descending monoaminergic pain modulation: bidirectional control and clinical relevance. Neurology 71 (2008) 217-221
95. Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol 80 (2006) 53-83
96. Proudfit H.K. Pharmacologic evidence for the modulation of nociception by noradrenergic neurons. Prog Brain Res 77 (1988) 357-370
97. Hodge Jr. C.J., Apkarian A.V., Owen M.P., and Hanson B.S. Changes in the effects of stimulation of locus coeruleus and nucleus raphe magnus following dorsal rhizotomy. Brain Res 288 (1983) 325-329
98. Voisin D.L., Guy N., Chalus M., and Dallel R. Nociceptive stimulation activates locus coeruleus neurones projecting to the somatosensory thalamus in the rat. J Physiol 566 (2005) 929-937
99. Clark F.M., and Proudfit H.K. Projections of neurons in the ventromedial medulla to pontine catecholamine cell groups involved in the modulation of nociception. Brain Res 540 (1991) 105-115
100. Holstege G. The emotional motor system. Eur J Morphol 30 (1992) 67-79
101. Nieuwenhuys R. The greater limbic system, the emotional motor system and the brain. Prog Brain Res 107 (1996) 551-580
102. Randich A., and Gebhart G.F. Vagal afferent modulation of nociception. Brain Res Brain Res Rev 17 (1992) 77-99
103. Stefanova N., Seppi K., Scherfler C., Puschban Z., and Wenning G.K. Depression in alpha-synucleinopathies: prevalence, pathophysiology and treatment. J Neural Transm Suppl (2000) 335-343
104. Slaughter J.R., Slaughter K.A., Nichols D., Holmes S.E., and Martens M.P. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 13 (2001) 187-196
105. Lemke M.R. Depressive symptoms in Parkinson's disease. Eur J Neurol 15 Suppl 1 (2008) 21-25
106. Cummings J.L. Depression and Parkinson's disease - a review. Amer J Psychiatry 149 (1992) 443-454
107. Ehmann T.S., Beninger R.J., Gawel M.J., and Riopelle R.J. Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects. J Geriatr Psychiatry Neurol 3 (1990) 3-9
108. Tandberg E., Larsen J.P., Aarsland D., and Cummings J.L. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 53 (1996) 175-179
109. Santamaria J., Tolosa E., and Valles A. Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 36 (1986) 1130-1133
110. Fukunishi I., Hosokawa K., and Ozaki S. Depression antedating the onset of Parkinson's disease. Jpn J Psychiatry Neurol 45 (1991) 7-11
111. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression, and mortality (reprinted from Neurology, vol 17, 1967). Neurology 57 (2001) 11-26
112. Merschdorf U., Berg D., Csoti I., Fornadi F., Merz B., Naumann M., et al. Psychopathological symptoms of depression in Parkinson's disease compared to major depression. Psychopathology 36 (2003) 221-225
113. Starkstein S.E., Preziosi T.J., Bolduc P.L., and Robinson R.G. Depression in Parkinson's disease. J Nerv Ment Dis 178 (1990) 27-31
114. Sargent P.A., Kjaer K.H., Bench C.J., Rabiner E.A., Messa C., Meyer J., et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57 (2000) 174-180
115. Jellinger K. Neuropathological correlations of mental dysfunction in Parkinson's disease: an update. In: Wolters E.C.H., Schulten P.H., Berendse H.W., and Utrecht (Eds). Mental dysfunction in Parkinson's disease (1999), Academic Pharmaceutical Productions, Utrecht 82-105
116. Damier P. The role of dopamine, serotonin, and noradrenaline in Parkinson's disease. In: Wolters E.C.H., Schulten P.H., Berendse H.W., and Utrecht (Eds). Mental dysfunction in Parkinson's disease (1999), Academic Pharmaceutical Productions, Utrecht 254-262
117. Remy P., Doder M., Lees A., Turjanski N., and Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128 (2005) 1314-1322
118. Mayberg H.S., and Solomon D.H. Depression in Parkinson's disease: a biochemical and organic viewpoint. Adv Neurol 65 (1995) 49-60
119. Syed A., Chatfield M., Matthews F., Harrison P., Brayne C., and Esiri M.M. Depression in the elderly: pathological study of raphe and locus ceruleus. Neuropathol Appl Neurobiol 31 (2005 Aug) 405-413
120. Taylor A.E., and Saint-Cyr J.A. Depression in Parkinson's disease: reconciling physiological and psychological perspectives. J Neuropsychiatry Clin Neurosci 2 (1990) 92-98
121. Yamamoto M., Pohli S., Durany N., Ozawa H., Saito T., Boissl K.W., et al. Increased levels of calcium-sensitive adenylyl cyclase subtypes in the limbic system of alcoholics: evidence for a specific role of cAMP signaling in the human addictive brain. Brain Res 895 (2001) 233-237
122. Berg D., Supprian T., Hofmann E., Zeiler B., Jager A., Lange K.W., et al. Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 246 (1999) 1186-1193
123. Kuhn W., Muller T., Gerlach M., Sofic E., Fuchs G., Heye N., et al. Depression in Parkinson's disease: biogenic amines in CSF of "de novo" patients. J Neural Transm 103 (1996) 1441-1445
124. Marsh G.G., and Markham C.H. Does levodopa alter depression and psychopathology in Parkinsonism patients?. J Neurol Neurosurg Psychiatry 36 (1973) 925-935
125. Mayeux R., Stern Y., Sano M., Williams J.B., and Cote L.J. The relationship of serotonin to depression in Parkinson's disease. Mov Disord 3 (1988) 237-244
126. McCance-Katz E.F., Marek K.L., and Price L.H. Serotonergic dysfunction in depression associated with Parkinson's disease. Neurology 42 (1992) 1813-1814
127. Yamamoto M. Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background. J Neurol 248 Suppl 3 (2001) 5-11
128. Doder M., Rabiner E.A., Turjanski N., Lees A.J., and Brooks D.J. Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study. Neurology 60 (2003) 601-605
129. Chan-Palay V., and Asan E. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without depression. J Comp Neurol 287 (1989) 373-392
130. Arnulf I., Leu S., and Oudiette D. Abnormal sleep and sleepiness in Parkinson's disease. Curr Opin Neurol 21 (2008) 472-477
131. Larsen J.P. Sleep disorders in Parkinson's disease. Adv Neurol 91 (2003) 329-334
132. Lees A.J., Blackburn N.A., and Campbell V.L. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 11 (1988) 512-519
133. Ondo W.G., Dat Vuong K., Khan H., Atassi F., Kwak C., and Jankovic J. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 57 (2001) 1392-1396
134. Schenck C.H., Bundlie S.R., and Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46 (1996) 388-393
135. Iranzo A., Molinuevo J.L., Santamaria J., Serradell M., Marti M.J., Valldeoriola F., et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5 (2006) 572-577
136. Hobson J.A., and Pace-Schott E.F. The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci 3 (2002) 679-693
137. Pace-Schott E.F., and Hobson J.A. The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3 (2002) 591-605
138. Hirsch E.C., Graybiel A.M., Duyckaerts C., and Javoy-Agid F. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci 84 (1987) 5976-5980
139. Turner R.S. Idiopathic rapid eye movement sleep behavior disorder is a harbinger of dementia with Lewy bodies. J Geriatr Psychiatry Neurol 15 (2002) 195-199
140. Parent A., and Steriade M. Afferents from the periaqueductal gray, medial hypothalamus and medial thalamus to the midbrain reticular core. Brain Res Bull 7 (1981) 411-418
141. Leonard C.S., and Llinas R. Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: an in vitro electrophysiological study. Neuroscience 59 (1994) 309-330
142. Edley S.M., and Graybiel A.M. The afferent and efferent connections of the feline nucleus tegmenti pedunculopontinus, pars compacta. J Comp Neurol 217 (1983) 187-215
143. Shute C.C., and Lewis P.R. The ascending cholinergic reticular system: neocortical, olfactory and subcortical projections. Brain 90 (1967) 497-520
144. Foote S.L., and Morrison J.H. Extrathalamic modulation of cortical function. Annu Rev Neurosci 10 (1987) 67-95
145. Saper C.B., Chou T.C., and Scammell T.E. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 24 (2001) 726-731
146. Steininger T.L., Gong H., McGinty D., and Szymusiak R. Subregional organization of preoptic area/anterior hypothalamic projections to arousal-related monoaminergic cell groups. J Comp Neurol 429 (2001) 638-653
147. Schenck C.H., and Mahowald M.W. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 25 (2002) 120-138
148. Fay R., and Kubin L. 5-HT(2A) receptor-like protein is present in small neurons located in rat mesopontine cholinergic nuclei, but absent from cholinergic neurons. Neurosci Lett 314 (2001) 77-81
149. Hendricks J.C., Morrison A.R., and Mann G.L. Different behaviors during paradoxical sleep without atonia depend on pontine lesion site. Brain Res 239 (1982) 81-105
150. Lai Y.Y., and Siegel J.M. Brainstem-mediated locomotion and myoclonic jerks. I. Neural substrates. Brain Res 745 (1997) 257-264
151. Lai Y.Y., and Siegel J.M. Medullary regions mediating atonia. J Neurosci 8 (1988) 4790-4796
152. Lai Y.Y., and Siegel J.M. In: Mallick B.N., and Inoue S. (Eds). Muscle atonia and REM sleep (1999), Marcel Dekker, New York 69-90
153. Jouvet M. Research on the neural structures and responsible mechanisms in different phases of physiological sleep. Arch Ital Biol 100 (1962) 125-206